Combined treatment with olmesartan medoxomil and amlodipine besylate attenuates atherosclerotic lesion progression in a model of advanced atherosclerosis

Combined treatment with olmesartan medoxomil and amlodipine besylate attenuates atherosclerotic lesion progression in a model of advanced atherosclerosis

Philipp Sievers,1 Lorenz Uhlmann,2 Sevil Korkmaz-Icöz,3 Christian Fastner,1 Florian Bea,1 Erwin Blessing,1 Hugo A Katus,1 Michael R Preusch11Department of Internal Medicine III, 2Institute of Medical Biometry and Informatics, 3Department of Cardiac Surgery, University of H...

Full description

Bibliographic Details
Main Authors:	Sievers P, Uhlmann L, Korkmaz-Icöz S, Fastner C, Bea F, Blessing E, Katus HA, Preusch MR
Format:	Article
Language:	English
Published:	Dove Medical Press 2015-07-01
Series:	Drug Design, Development and Therapy
Online Access:	http://www.dovepress.com/combined-treatment-with-olmesartan-medoxomil-and-amlodipine-besylate-a-peer-reviewed-article-DDDT

Similar Items

Development and Validation of a Chromatography Method Using Tandem UV/Charged Aerosol Detector for Simultaneous Determination of Amlodipine Besylate and Olmesartan Medoxomil: Application to Drug-Excipient Compatibility Study
by: Ariadne M. Brondi, et al.
Published: (2017-01-01)

Ticagrelor promotes atherosclerotic plaque stability in a mouse model of advanced atherosclerosis
by: Preusch MR, et al.
Published: (2016-08-01)

Critical appraisal of amlodipine and olmesartan medoxomil fixed-dose combination in achieving blood pressure goals
by: Jan Basile
Published: (2010-06-01)

Safety and tolerability of fixed antihypertensive combinations in blood pressure control: focus on olmesartan medoxomil and amlodipine combination
by: Ijlal Uddin, et al.
Published: (2010-11-01)

Optimal therapeutic strategy for treating patients with hypertension and atherosclerosis: focus on olmesartan medoxomil
by: R. P. Mason
Published: (2012-06-01)

Optimal therapeutic strategy for treating patients with hypertension and atherosclerosis: focus on olmesartan medoxomil
by: Mason
Published: (2011-06-01)

Bioequivalence evaluation of two amlodipine salts, besylate and orotate, each in a fixed-dose combination with olmesartan in healthy subjects
by: Lee SY, et al.
Published: (2015-06-01)

Inclusion complexes of amlodipine besylate and cyclodextrins
by: Kapor Agneš, et al.
Published: (2010-08-01)

Olmesartan medoxomil combined with hydrochlorothiazide for the treatment of hypertension
by: Mark Greathouse
Published: (2006-12-01)

Olmesartan medoxomil for the treatment of hypertension in children and adolescents
by: Volpe M, et al.
Published: (2011-03-01)

EVALUATION OF ANTIHYPERTENSIVE THERAPY WITH THE COMBINATION OF OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE
by: Steven G. Chrysant, et al.
Published: (2011-06-01)

Development and characterization of nanosuspensions of olmesartan medoxomil for bioavailability enhancement
by: Hetal Paresh Thakkar, et al.
Published: (2011-01-01)

Olmesartan medoxomil: current status of its use in monotherapy
by: Hans R Brunner
Published: (2006-12-01)

Formulation and evaluation of S-(-)-Amlodipine besylate and nebivolol hydrochloride tablets
by: S A Shaikh, et al.
Published: (2010-01-01)

FORMULATION AND EVALUATION OF S-(-)-AMLODIPINE BESYLATE AND NEBIVOLOL HYDROCHLORIDE TABLETS
by: Shaikh S.A, et al.
Published: (2010-06-01)

Synthesis of related substances of olmesartan medoxomil, an anti-hypertensive drug
by: Karrothu S. Babu, et al.
Published: (2010-05-01)

Integrated control of hypertension by olmesartan medoxomil and hydrochlorothiazide and rationale for combination
by: Punzi HA
Published: (2011-12-01)

UV Spectrophotometric Determination of Hydrochlorothiazide and Olmesartan Medoxomil in Pharmaceutical Formulation
by: A. T. Hemke, et al.
Published: (2010-01-01)

Amlodipine Besylate has no Adverse Effect on Male Hormonal Profile
Published: (2016-11-01)

Design of Olmesartan Medoxomil-Loaded Nanosponges for Hypertension and Lung Cancer Treatments
by: Bjad K. Almutairy, et al.
Published: (2021-07-01)

EFFECT OF ANGIOTENSIN RECEPTOR BLOCKADE ON ENDOTHELIAL FUNCTION: FOCUS ON OLMESARTAN MEDOXOMIL
by: C. Ferrario
Published: (2010-12-01)

Olmesartan medoxomil-loaded mixed micelles: Preparation, characterization and in-vitro evaluation
by: Mohamed A. El-Gendy, et al.
Published: (2017-12-01)

Effect of angiotensin receptor blockade on endothelial function: focus on olmesartan medoxomil
by: Carlos Ferrario
Published: (2009-03-01)

Synthesis and Characterization of Process-Related Impurities of Antihypertensive Drug Olmesartan Medoxomil
by: G. Venkanna, et al.
Published: (2013-01-01)

Kinetic spectrophotometric method for determination of amlodipine besylate in its pharmaceutical tablets
by: Ashraf M. Mahmoud, et al.
Published: (2012-10-01)

PROTECTIVE EFFECTS OF ANGIOTENSIN II BLOCKADE WITH OLMESARTAN MEDOXOMIL ON RESISTANCE VESSEL REMODELING
by: Ronald D. Smith, et al.
Published: (2010-10-01)

Stability-indicating comparative methods using mekc and lc for determination of olmesartan medoxomil
by: Lisiane Bajerski, et al.
Published: (2013-01-01)

Stability-indicating comparative methods using mekc and lc for determination of olmesartan medoxomil
by: Lisiane Bajerski, et al.
Published: (2013-01-01)

Combination Therapy with Olmesartan and Amlodipine in the Treatment of Hypertension
by: Menco G. Niemeijer, et al.
Published: (2009-12-01)

Development and validation of stability-indicating RP-HPLC method for determination of Olmesartan medoxomile in pharmaceutical dosage form and identification, characterization of alkaline degradation impurity of Olmesartan medoxomile drug substance as well as drug product
by: Jain P.S., et al.
Published: (2012-01-01)

Enhanced ex vivo intestinal absorption of olmesartan medoxomil nanosuspension: Preparation by combinative technology
by: Zenab Attari, et al.
Published: (2016-01-01)

Olmesartan Medoxomil, An Angiotensin II-Receptor Blocker, Ameliorates Renal Injury In db/db Mice
by: Zhu Y, et al.
Published: (2019-10-01)

Use of transethosomes for enhancing the transdermal delivery of olmesartan medoxomil: in vitro, ex vivo, and in vivo evaluation
by: Albash R, et al.
Published: (2019-03-01)

Blood pressure goal achievement with olmesartan medoxomil-based treatment: additional analysis of the OLMEBEST study
by: Vivencio Barrios, et al.
Published: (2009-08-01)

Efficacy of olmesartan amlodipine in Colombian hypertensive patients (soat study)
by: Richard Buendia, et al.
Published: (2017-04-01)

Olmesartan/amlodipine: a review of its use in the management of hypertension
by: Kreutz R
Published: (2011-03-01)

Electrochemical Biosensor for the Determination of Amlodipine Besylate Based on Gelatin–Polyaniline Iron Oxide Biocomposite Film
by: Elbahi Djaalab, et al.
Published: (2018-06-01)

Simultaneous Detemination of Atorvastatin Calcium and Amlodipine Besylate by Spectrophotometry and Multivariate Calibration Methods in Pharmaceutical Formulations
by: Amir H. M. Sarrafi, et al.
Published: (2011-01-01)

Study of forced degradation of amlodipine besylate and bisoprolol fumarate by application of hydrophilic interaction liquid chromatography
by: Kasagić-Vujanović Irena, et al.
Published: (2014-01-01)

Development of a novel 96-microwell assay with high throughput for determination of olmesartan medoxomil in its tablets
by: Darwish Ibrahim A, et al.
Published: (2012-01-01)